Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-PSMA-11 and 68Ga-RM2 PET/MRI for Prostate Cancer Response
NCT03949517Phase 2Completed
- Sponsor
- Andrei Iagaru
- Start
- Apr 2019
- Primary completion
- Mar 2022
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by Andrei Iagaru. Primary endpoint: Number of Participants for Which an Assessment of PET Based Therapeutic Response to HIFU is Successfully Obtained up to 2 hours. Started Apr 2019; status: completed.
Beyond the preview
Go deeper on NCT03949517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03949517.